Drugs that suppress IL-6 release, such as tocilizumab, are used in the treatment of rheumatoid arthritis and juvenile rheumatoid arthritis, and are among the possible future treatment options of pustular psoriasis.32 Here, IL6 is linked to juvenile idiopathic arthritis.